Steve Austin

University of South Florida — United States

Medicine · Health Sciences

35h-index4.8kcitations121works7.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemophilia Treatment and Research(33), Platelet Disorders and Treatments(25), Blood Coagulation and Thrombosis Mechanisms(22), Coagulation, Bradykinin, Polyphosphates, and Angioedema(14), Chronic Myeloid Leukemia Treatments(12)

Publications116 total

CovCIFDock: Covalent Docking with CIFDock and Hybrid QM/MM Minimizations
2025Open Access
Evaluating the Impact of Peer Based Services and Multi-Sector Collaboration on Opioid Use, Overdose, and Treatment Utilization Among Criminal Justice-Involved Individuals with Opioid Use or Misuse 
2024Open Access
A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia
Blood·2024
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database
Blood Advances·2024· 35 citedOpen Access
Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel
Haemophilia·2024· 2 citedOpen Access
Editorial Board
British Journal of Oral and Maxillofacial Surgery·2023Open Access
An open‐label, multi‐centre, post‐marketing study to assess the efficacy and safety of a plasma‐derived VWF/FVIII concentrate in patients with von Willebrand disease
Haemophilia·2023· 2 citedOpen Access
A Phase 1/2, First-in-Human, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia
Blood·2023· 1 citedOpen Access
Editorial Board
British Journal of Oral and Maxillofacial Surgery·2023Open Access
Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy
Blood·2022· 23 citedOpen Access
Identification of Potential SARS-CoV-2 Inhibitors Using Flexible Docking Based Drug Repurposing of Antivirals
2022Open Access
Seroprevalence to adeno‐associated virus type 6 in people with hemophilia B from a UK adult cohort
Research and Practice in Thrombosis and Haemostasis·2022· 6 citedOpen Access
The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international study
Research and Practice in Thrombosis and Haemostasis·2022· 102 citedOpen Access
Rare missense variants in Tropomyosin‐4 (TPM4) are associated with platelet dysfunction, cytoskeletal defects, and excessive bleeding
Journal of Thrombosis and Haemostasis·2021· 7 citedOpen Access
Plasma‐derived factor X concentrate compassionate use for hereditary factor X deficiency: Long‐term safety and efficacy in a retrospective data‐collection study
Research and Practice in Thrombosis and Haemostasis·2021· 5 citedOpen Access
Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency
Blood Reviews·2021· 31 citedOpen Access
Haemostasis
Medicine·2021· 1 cited
Real-World Clinical and Laboratory Characteristics in Severe Hemophilia a Patients Commencing Emicizumab
Blood·2020
Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort
Nature·2020· 6 citedOpen Access
Whole-genome sequencing of a sporadic primary immunodeficiency cohort
Nature·2020· 229 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Emma Clement(9), Tadbir K. Bariana(9), Sofie Ashford(9), John R. Bradley(8), Willem H. Ouwehand(7), F. Lucy Raymond(7), Matthew A. Brown(7), Peter Collins(7), Carolyn M. Millar(7), Keren Carss(6), Kathleen Stirrups(6), Timothy J. Aitman(6), David Allsup(6), Tamam Bakchoul(6), Lawrence T. Weaver(6), Daniel Greene(6), P. G. Lunn(6), Jonathan Stephens(5), Christopher J. Penkett(5), Maria Bitner‐Glindzicz(5)